分组1 - Choice Hotels reported quarterly earnings of $2.1 per share, missing the Zacks Consensus Estimate of $2.18 per share, and down from $2.23 per share a year ago, representing an earnings surprise of -3.67% [1] - The company posted revenues of $447.34 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 7.20%, compared to year-ago revenues of $427.96 million [2] - Over the last four quarters, Choice Hotels has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] 分组2 - Choice Hotels shares have lost about 35.6% since the beginning of the year, while the S&P 500 has gained 15.1% [3] - The current consensus EPS estimate for the coming quarter is $1.57 on revenues of $370.44 million, and for the current fiscal year, it is $7.00 on revenues of $1.55 billion [7] - The Zacks Industry Rank for Hotels and Motels is currently in the bottom 21% of over 250 Zacks industries, indicating potential underperformance compared to the top 50% of ranked industries [8]

Core Insights - Dine Brands (DIN) reported quarterly earnings of $0.73 per share, missing the Zacks Consensus Estimate of $0.82 per share, and down from $1.44 per share a year ago, representing an earnings surprise of -10.98% [1] - The company posted revenues of $216.17 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 0.54%, but up from $195.03 million year-over-year [2] - Dine Brands shares have declined approximately 18.3% year-to-date, contrasting with the S&P 500's gain of 15.1% [3] Earnings Outlook - The company's earnings outlook is crucial for investors, including current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is $0.90 on revenues of $226.56 million, and for the current fiscal year, it is $3.93 on revenues of $889.46 million [7] Industry Context - The Retail - Restaurants industry, to which Dine Brands belongs, is currently ranked in the bottom 13% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor sentiment [5]

Company Performance - Zimmer Biomet reported quarterly earnings of $1.9 per share, exceeding the Zacks Consensus Estimate of $1.88 per share, and up from $1.74 per share a year ago, representing an earnings surprise of +1.06% [1] - The company posted revenues of $2 billion for the quarter ended September 2025, which was below the Zacks Consensus Estimate by 0.42%, but an increase from $1.82 billion year-over-year [2] - Over the last four quarters, Zimmer has surpassed consensus EPS estimates four times and topped consensus revenue estimates three times [2] Stock Outlook - Zimmer shares have declined approximately 2.3% since the beginning of the year, contrasting with the S&P 500's gain of 15.1% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the upcoming quarter is $2.39 on revenues of $2.23 billion, and for the current fiscal year, it is $8.15 on revenues of $8.22 billion [7] Industry Context - The Medical - Products industry, to which Zimmer belongs, is currently ranked in the bottom 40% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5][6]

Core Insights - Acushnet reported quarterly earnings of $0.81 per share, missing the Zacks Consensus Estimate of $0.85 per share, and down from $0.89 per share a year ago, representing an earnings surprise of -4.71% [1] - The company posted revenues of $657.66 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 3.78% and up from $620.5 million year-over-year [2] - Acushnet shares have increased approximately 5.9% year-to-date, compared to a 15.1% gain in the S&P 500 [3] Earnings Performance - Over the last four quarters, Acushnet has surpassed consensus EPS estimates two times [2] - The company had a previous earnings expectation of $1.33 per share, but reported $1.25, resulting in a surprise of -6.02% [1] Future Outlook - The company's earnings outlook will be crucial for stock performance, with current consensus EPS estimates at -$0.23 for the upcoming quarter and $3.47 for the current fiscal year [7] - The Zacks Rank for Acushnet is currently 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6] Industry Context - The Leisure and Recreation Products industry, to which Acushnet belongs, is currently ranked in the top 27% of over 250 Zacks industries, suggesting a favorable industry outlook [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Acushnet's stock performance [5]

Core Insights - Hackett Group reported quarterly earnings of $0.37 per share, matching the Zacks Consensus Estimate, but down from $0.43 per share a year ago [1] - The company posted revenues of $72.17 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 2.02% and down from $77.95 million year-over-year [2] - Hackett Group shares have declined approximately 41.4% year-to-date, contrasting with the S&P 500's gain of 16.5% [3] Earnings Performance - The company has surpassed consensus EPS estimates two times over the last four quarters [1] - Hackett Group has topped consensus revenue estimates three times in the last four quarters [2] - The current consensus EPS estimate for the upcoming quarter is $0.38, with expected revenues of $75.1 million, and for the current fiscal year, the estimate is $1.52 on revenues of $302.58 million [7] Market Outlook - The stock's immediate price movement will largely depend on management's commentary during the earnings call [3] - The estimate revisions trend for Hackett Group was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] - The Consulting Services industry is currently ranked in the top 26% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

Core Insights - Agilon Health (AGL) reported a quarterly loss of $0.27 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.18, marking an earnings surprise of -50.00% [1] - The company generated revenues of $1.44 billion for the quarter ended September 2025, slightly surpassing the Zacks Consensus Estimate by 0.57%, but down from $1.45 billion a year ago [2] - Agilon shares have declined approximately 57.4% year-to-date, contrasting with the S&P 500's gain of 16.5% [3] Financial Performance - Over the last four quarters, Agilon has exceeded consensus EPS estimates only once [2] - The current consensus EPS estimate for the upcoming quarter is -$0.19 on revenues of $1.47 billion, and for the current fiscal year, it is -$0.56 on revenues of $5.82 billion [7] Market Outlook - The company's Zacks Rank is currently 3 (Hold), indicating expected performance in line with the market in the near future [6] - The Medical Services industry, to which Agilon belongs, is ranked in the bottom 43% of over 250 Zacks industries, suggesting potential challenges ahead [8]

Core Insights - Par Petroleum (PARR) reported quarterly earnings of $5.95 per share, significantly exceeding the Zacks Consensus Estimate of $1.98 per share, and compared to a loss of $0.1 per share a year ago, representing an earnings surprise of +200.51% [1] - The company posted revenues of $2.01 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.40%, although this is a decrease from year-ago revenues of $2.14 billion [2] - Par Petroleum shares have increased by approximately 151.4% since the beginning of the year, outperforming the S&P 500's gain of 16.5% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.43 on revenues of $1.81 billion, and for the current fiscal year, it is $3.89 on revenues of $7.36 billion [7] - The estimate revisions trend for Par Petroleum was favorable ahead of the earnings release, resulting in a Zacks Rank 1 (Strong Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Oil and Gas - Refining and Marketing industry is currently ranked in the top 18% of over 250 Zacks industries, suggesting a positive outlook for stocks within this sector [8] - Another company in the same industry, Delek US Holdings (DK), is expected to report quarterly earnings of $0.14 per share, reflecting a year-over-year change of +109.7%, with a consensus EPS estimate revised 36.9% higher over the last 30 days [9]

Core Insights - Latham Group reported quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.10 per share, representing a -20.00% earnings surprise [1] - The company posted revenues of $161.9 million for the quarter ended September 2025, which was 1.28% below the Zacks Consensus Estimate, compared to $150.5 million in the same quarter last year [2] Earnings Performance - Over the last four quarters, Latham Group has surpassed consensus EPS estimates two times [2] - The company had a previous quarter earnings expectation of $0.13 per share but reported $0.14, resulting in a +7.69% surprise [1] Stock Performance - Latham Group shares have increased approximately 4.5% since the beginning of the year, while the S&P 500 has gained 16.5% [3] Future Outlook - The company's earnings outlook will be crucial for investors, including current consensus earnings expectations for upcoming quarters [4] - The current consensus EPS estimate for the next quarter is -$0.09 on revenues of $93 million, and $0.10 on revenues of $541 million for the current fiscal year [7] Industry Context - The Building Products - Miscellaneous industry, to which Latham Group belongs, is currently ranked in the bottom 39% of over 250 Zacks industries, indicating potential challenges [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Latham Group's stock performance [5][6]

Group 1 - CeriBell, Inc. reported a quarterly loss of $0.37 per share, better than the Zacks Consensus Estimate of a loss of $0.43, and an improvement from a loss of $1.85 per share a year ago, resulting in an earnings surprise of +13.95% [1] - The company posted revenues of $22.59 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 3.65%, and showing an increase from $17.19 million in the same quarter last year [2] - CeriBell, Inc. has surpassed consensus EPS estimates three times over the last four quarters and has topped consensus revenue estimates four times in the same period [2] Group 2 - The stock has underperformed, losing about 56.2% since the beginning of the year, while the S&P 500 has gained 16.5% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.42 on revenues of $23.33 million, and for the current fiscal year, it is -$1.55 on revenues of $86.82 million [7] - The Zacks Industry Rank for Medical - Products is in the bottom 41% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

Core Insights - CryoPort, Inc. reported a quarterly loss of $0.18 per share, better than the Zacks Consensus Estimate of a loss of $0.23, representing an earnings surprise of +21.74% [1] - The company posted revenues of $44.23 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 8.32%, although this is a decline from $56.66 million in the same quarter last year [2] - CryoPort shares have increased by approximately 16.2% year-to-date, slightly underperforming the S&P 500's gain of 16.5% [3] Earnings Outlook - The earnings outlook for CryoPort is mixed, with the current consensus EPS estimate for the upcoming quarter at -$0.20 on revenues of $43.17 million, and -$0.85 on revenues of $170.5 million for the current fiscal year [7] - The company's Zacks Rank is currently 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Medical Services industry, to which CryoPort belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, suggesting potential challenges ahead [8] - The Oncology Institute, Inc., another company in the same industry, is expected to report a quarterly loss of $0.12 per share, with revenues projected to be $122.25 million, reflecting a year-over-year increase of 22.4% [9][10]